UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

The New England journal of medicine, 2020-09, Vol.383 (10), p.931-943

2020

Volltextzugriff (PDF)

First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

Journal of thoracic oncology, 2016-03, Vol.11 (3), p.380-390

2016

Volltextzugriff (PDF)

Toxicities of Immunotherapy for the Practitioner

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2092-2099

2015

Volltextzugriff (PDF)

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

Nature medicine, 2016-04, Vol.22 (4), p.433-438

2016

Volltextzugriff (PDF)

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors

The Journal of clinical investigation, 2014-05, Vol.124 (5), p.2246-2259

2014

Volltextzugriff (PDF)

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors

Nature communications, 2019-09, Vol.10 (1), p.4016-13, Article 4016

2019

Volltextzugriff (PDF)

Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-03, Vol.36 (9), p.841-849

2018

Volltextzugriff (PDF)

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers

Clinical cancer research, 2019-03, Vol.25 (5), p.1486-1493

2019

Volltextzugriff (PDF)

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3592-3603

2020

Volltextzugriff (PDF)

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Nature reviews. Cancer, 2008-04, Vol.8 (4), p.299-308

2008

Volltextzugriff (PDF)

Efficacy of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcoma of the Extremity: 20-year Follow-Up of a Randomized Prospective Trial

Annals of surgical oncology, 2014-08, Vol.21 (8), p.2484-2489

2014

Volltextzugriff (PDF)

Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes

The Journal of clinical investigation, 2019-11, Vol.129 (11), p.4992-5004

2019

Volltextzugriff (PDF)

Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma

Journal of immunotherapy, 2010-10, Vol.33 (8), p.828-833

2010

Volltextzugriff (PDF)

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Journal of clinical oncology, 2011-03, Vol.29 (7), p.917-924

2011

Volltextzugriff (PDF)

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

Journal of immunotherapy (1997), 2013-02, Vol.36 (2), p.133-151

2013

Volltextzugriff (PDF)

Cancer immunotherapy: moving beyond current vaccines

Nature medicine, 2004-09, Vol.10 (9), p.909-915

2004

Volltextzugriff (PDF)

Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers

Clinical cancer research, 2017-05, Vol.23 (9), p.2267-2276

2017

Volltextzugriff (PDF)

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5233-5239

2008

Volltextzugriff (PDF)

Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens

Cancer Immunology, Immunotherapy, 2023-10, Vol.72 (10), p.3149-3162

2023

Volltextzugriff (PDF)

Landscape of Tumor Antigens in T Cell Immunotherapy

The Journal of immunology (1950), 2015-12, Vol.195 (11), p.5117-5122

2015

Volltextzugriff (PDF)

Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2152-2159

2013

Volltextzugriff (PDF)

The ongoing mystery of renal cell cancer

Cell reports. Medicine, 2021-11, Vol.2 (11), p.100445-100445, Article 100445

Yang, James C.

2021

Volltextzugriff (PDF)

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

Science (American Association for the Advancement of Science), 2006-10, Vol.314 (5796), p.126-129

2006

Volltextzugriff (PDF)

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Clinical cancer research, 2006-10, Vol.12 (20), p.6106-6115

2006

Volltextzugriff (PDF)

1 – 25 von 1.382

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.233)
Mit Volltextzugriff
(1.190)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.370)
Chinesisch
(5)
Japanisch
(5)
Deutsch
(2)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(884)
Life Sciences & Biomedicine
(635)
Humans
(488)
Female
(249)
Male
(234)
Animals
(209)
Oncology
(185)
Middle Aged
(178)
Biological And Medical Sciences
(173)
Adult
(155)
Medical Sciences
(143)
Technology
(137)
Physical Sciences
(129)
Aged
(116)
Mice
(111)
Science & Technology - Other Topics
(103)
Multidisciplinary Sciences
(87)
Immunotherapy
(82)
Engineering
(80)
Pharmacology. Drug Treatments
(72)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

Toxicities of Immunotherapy for the Practitioner

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors

Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Efficacy of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcoma of the Extremity: 20-year Follow-Up of a Randomized Prospective Trial

Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes

Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study

Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

Cancer immunotherapy: moving beyond current vaccines

Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens

Landscape of Tumor Antigens in T Cell Immunotherapy

Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

The ongoing mystery of renal cell cancer

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Suchergebnisse filtern